TET: Test Evidence Transition

Cancer Research UK's (CRUK) ‘Test, Evidence, Transition’ programme aims to accelerate the effective adoption of service innovations whilst working to improve access for everyone to proven interventions. The programme has three objectives:

Test service innovations to support optimal cancer pathways- at a local level
Evidence the process, outcome, and impact of implementation at a local level using appropriate methods
Work with strategic partners to enable the effective and equitable Transition of identified best practice into mainstream practice across the health system

This programme is now in Phase 2, building on the success of Phase 1 and the earlier Accelerate, Coordinate, Evaluate (ACE) programme. Headed by Associate Professor Brian D Nicholson, Senior researcher Anna Dowrick and from the University of Cambridge, Juliet Usher-Smith.

WHAT WE ARE DOING

This phase of the programme is seeking to optimise both the screening and symptomatic pathways to improve the early detection and diagnosis of colorectal cancers. We are working with frontline Health Service Delivery teams across England, Wales and Scotland, the Test Evidence Transition programme team, and wider health systems stakeholders to co-design, deliver and evaluate targeted service improvement and innovation projects, generating evidence to enable effective and equitable adoption into mainstream practice.

Expected Impact

Through this work we will support health service delivery teams to improve their rates of colorectal cancer detection. In doing so, we will develop understanding about how to make sustainable innovation in colorectal cancer services that can be scaled-up across the UK.

This project is funded by Cancer Research UK

Cancer Research UK Homepage.png